
Olcadia 1mg Tablet (Evocalcet)
1mg
Tablet · Prescription medication
DKSH Korea Co., Ltd.
EvoCalset is a medication used in the treatment of hyperparathyroidism.
MFDS ingredient code M268361
EvoCalset is composed of agents belonging to the calcium-sensing receptor agonist class, which is used to regulate the excessive secretion of parathyroid hormone from the parathyroid glands. It is primarily utilized in the treatment of hyperparathyroidism in patients with chronic kidney disease.
EvoCalset activates the calcium-sensing receptors on the surface of parathyroid cells, allowing them to detect calcium levels in the blood. This leads to the suppression of parathyroid hormone secretion, thereby regulating blood calcium levels.
Approved uses differ by product. Check each product's information for its actual use.
EvoCalset is distinguished by having fewer side effects and more stable efficacy compared to traditional calcimimetics. Additionally, it allows for more precise regulation of blood calcium levels, resulting in superior therapeutic effects.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.